Why the study?
Does targeted, nurse-led case finding increase the prescription of antihypertensives or statins in untreated patients at high risk of cardiovascular disease?
Does targeted, nurse-led case finding increase the prescription of antihypertensives or statins in untreated patients at high risk of cardiovascular disease?
A targeted, nurse-led case finding program significantly increases the initiation of preventive treatments (antihypertensives and statins) in high-risk cardiovascular patients.
Answers are grounded in this paper and cite their sources.
Targeted nurse-led case finding was associated with higher treatment rates; leaves open whether systematic programs improve CVD outcomes in routine care.
BACKGROUND: Individuals at high risk of cardiovascular disease (CVD) are undertreated. AIM: To evaluate the effectiveness of a programme of targeted, nurse-led case finding for CVD prevention in primary care. DESIGN AND SETTING: Targeted case finding for CVD prevention was implemented in urban West Midlands general practices between February 2009 and August 2012, and evaluated as a stepped wedge cluster randomised trial. METHOD: Untreated patients aged 35-74 years and at ≥20% 10-year CVD risk were identified, invited for assessment by a project nurse, and referred to their GP for treatment initiation. The primary outcome was the proportion of high-risk patients prescribed antihypertensives or statins after exposure to the intervention compared with an equivalent period of time prior to exposure. Secondary outcomes included assessment of CVD risk factors. RESULTS: In 26 sequentially randomised general practices the exposed group consisted of 2926 untreated high-risk patients identified at the start of the intervention, with 2969 patients identified at the start of the unexposed period. The trial was well balanced in terms of age, sex, and cardiovascular risk factors. In the exposed period 19.7% of patients were prescribed antihypertensives or statins, and 10.8% of patients in the unexposed period. After adjustment for clustering and temporal effects the risk difference was 15.5% (95% CI = 3.9 to 27.1, P = 0.009). Assessment of lipid levels increased significantly, at 26.4% (99% CI = 5.3 to 47.5, P = 0.001) CONCLUSION: Targeted case finding programmes can increase the number of high-risk patients started on antihypertensive and statin treatment.
No takes yet. Share an insight, caveat, or question.
Hemming et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: